Discovering New Drug Targets Or Biomarkers for Cancer Treatment

Target Name: Adaptor-related protein complex 1

NCBI ID: P7027

Adaptor-related protein complex 1

Other Name(s): AP1 adaptor complex | Adaptor protein complex 1 (AP-1) | AP-1 complex

Discovering New Drug Targets Or Biomarkers for Cancer Treatment

Adaptor-related protein complex 1 (AP1 adapter complex) is a protein complex that plays a critical role in the process of protein synthesis in eukaryotic cells. It is composed of several proteins that work together to recognize, bind and transport specific proteins. Under normal circumstances, AP1 adapter complex 1 is a protein complex composed of multiple subunits, including: AP1, AP2, AP3, AP4 and AP5.

The function of AP1 adapter complex 1 is to bind to initiation factors in the protein translation process in cells, thereby enabling RNA polymerase to bind to ribosomes. It is the binding partner of RNA polymerase II (RNA-II), the enzyme responsible for transcribing DNA into RNA. By binding to RNA-II, AP1 adapter complex 1 is able to recognize and bind to a specific region on RNA-II, allowing it to bind to ribosomes and initiate protein synthesis.

The composition and structure of AP1 adapter complex 1 are critical to its function. Multiple research groups have conducted in-depth studies on the structure and function of AP1 adapter complex 1 and proposed some hypotheses. For example, subunits of AP1 adapter complex 1 can bind to specific regions on RNA-II, and different subunits may bind to different regions. In addition, subunits of AP1 adapter complex 1 can interact with each other to form a stable protein complex.

The role of AP1 adapter complex 1 in cancer has also attracted attention. Many studies have shown that the expression level of AP1 adapter complex 1 changes in various cancers and is related to cancer progression and treatment response. For example, expression levels of AP1 adapter complex 1 are positively correlated with progression and treatment response in cancers such as breast, lung, and colon cancer. In addition, AP1 adapter complex 1 is also related to the apoptosis and proliferation of tumor cells. Therefore, AP1 adapter complex 1 may be a potential drug target or biomarker.

Currently, a variety of drugs have been developed to treat cancer, but most of them target specific tumor cell types or specific pathological characteristics. Therefore, discovering new drug targets or biomarkers is of great significance. AP1 adapter complex 1 is a potential drug target or biomarker because it is a key protein expressed in a variety of cancers. By deeply studying the structure and function of AP1 adapter complex 1, new drug targets or biomarkers can be discovered and the treatment of cancer can be promoted.

Protein Name: Adaptor-related Protein Complex 1

The "Adaptor-related protein complex 1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Adaptor-related protein complex 1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets